Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
The Canadian Journal of Urology
|
January 1, 1994
Peyronie's disease: developments in diagnosis and treatment
P Zvara, G B Brock
Current Opinion in Urology
|
December 6, 2001
Modern pharmacotherapy for erectile dysfunction: evolving concepts with central and peripheral acting agents
G B Brock, D Bochinski
Drug Safety
|
June 1, 1993
Drug-induced male sexual dysfunction. An update
G B Brock, T F Lue
The Urologic Clinics of North America
|
June 14, 2001
Priapism. From Priapus to the present time
S E Pautler, G B Brock
Current Pharmaceutical Design
|
October 29, 2009
Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: preference and adherence to treatment
T F Al-Shaiji, G B Brock
Cancer Research
|
January 27, 1998
Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes and with an increase in IGF binding protein 3
H Huynh, R M Seyam, G B Brock
International Journal of Impotence Research
|
July 22, 2011
Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literature
E Chung, L De Young, G B Brock
The Journal of Urology
|
September 24, 1999
The impact of chronic renal failure on nitric oxide synthase isoforms gene expression in the penis and pelvic ganglia of rats
M Abdel-Gawad, H Huynh, G B Brock
Endocrinology
|
June 30, 1998
Improvement of erectile function in diabetic rats by insulin: possible role of the insulin-like growth factor system
T M Abdelbaky, G B Brock, H Huynh
International Journal of Impotence Research
|
January 19, 2000
Neuronal and endothelial nitric oxide synthase isoforms: quantification of protein and mRNA in the normal rat penis
R M Seyam, H T Huynh, G B Brock
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
The Canadian Journal of Urology
|
January 1, 1994
Peyronie's disease: developments in diagnosis and treatment
P Zvara, G B Brock
Current Opinion in Urology
|
December 6, 2001
Modern pharmacotherapy for erectile dysfunction: evolving concepts with central and peripheral acting agents
G B Brock, D Bochinski
Drug Safety
|
June 1, 1993
Drug-induced male sexual dysfunction. An update
G B Brock, T F Lue
The Urologic Clinics of North America
|
June 14, 2001
Priapism. From Priapus to the present time
S E Pautler, G B Brock
Current Pharmaceutical Design
|
October 29, 2009
Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: preference and adherence to treatment
T F Al-Shaiji, G B Brock
Cancer Research
|
January 27, 1998
Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes and with an increase in IGF binding protein 3
H Huynh, R M Seyam, G B Brock
International Journal of Impotence Research
|
July 22, 2011
Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literature
E Chung, L De Young, G B Brock
The Journal of Urology
|
September 24, 1999
The impact of chronic renal failure on nitric oxide synthase isoforms gene expression in the penis and pelvic ganglia of rats
M Abdel-Gawad, H Huynh, G B Brock
Endocrinology
|
June 30, 1998
Improvement of erectile function in diabetic rats by insulin: possible role of the insulin-like growth factor system
T M Abdelbaky, G B Brock, H Huynh
International Journal of Impotence Research
|
January 19, 2000
Neuronal and endothelial nitric oxide synthase isoforms: quantification of protein and mRNA in the normal rat penis
R M Seyam, H T Huynh, G B Brock
Page
of 4